Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir”

220 trials

Showing 20 of 220 results

Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Large-scale testing (Phase 3)Study completedNCT00424814
What this trial is testing

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 105
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Post-approval studies (Phase 4)Study completedNCT01772940
What this trial is testing

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Who this might be right for
HIV-1 Infection
Centre Hospitalier Universitaire Saint Pierre 425
Testing effectiveness (Phase 2)Study completedNCT00038532
What this trial is testing

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Who this might be right for
HIV Infections
Abbott 24
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Post-approval studies (Phase 4)UnknownNCT04350684
What this trial is testing

Umifenovir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Post-approval studies (Phase 4)Study completedNCT00869700
What this trial is testing

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Who this might be right for
HIV InfectionsMalaria
University of Cape Town 18
Not applicableStudy completedNCT00041964
What this trial is testing

HIV Levels During Pregnancy and After Childbirth

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 129
Post-approval studies (Phase 4)Study completedNCT01533272
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Testing effectiveness (Phase 2)Study completedNCT04499677
What this trial is testing

FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals

Who this might be right for
COVID-19
University College, London 240
Testing effectiveness (Phase 2)UnknownNCT00017992
What this trial is testing

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 100
Testing effectiveness (Phase 2)Study completedNCT00621166
What this trial is testing

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 20
Early research (Phase 1)Ended earlyNCT00743470
What this trial is testing

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Who this might be right for
HIVTuberculosis
Abbott 15
Early research (Phase 1)Study completedNCT00665951
What this trial is testing

Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

Who this might be right for
HIV Infections
Radboud University Medical Center 12
Post-approval studies (Phase 4)UnknownNCT04350671
What this trial is testing

Interferon Beta 1a in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Post-approval studies (Phase 4)Study completedNCT00626301
What this trial is testing

Lopinavir/Ritonavir Monotherapy in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 40
Large-scale testing (Phase 3)Study completedNCT01002898
What this trial is testing

Ritonavir-boosted Lopinavir Monotherapy

Who this might be right for
HIV
Bamrasnaradura Infectious Diseases Institute 40
Large-scale testing (Phase 3)Study completedNCT00086359
What this trial is testing

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation